Leukocyte Effects of C5a-Receptor Blockade During Simulated Extracorporeal Circulation

Annals of Thoracic Surgery

Volumn 83, Issue 1, 2007, Pages 146-152

  Rinder, Christine S ^a   Smith, Michael J ^b   Rinder, Henry M ^a   Cortright, Daniel N ^a   Brodbeck, Robbin M ^a   Krause, James E ^c   Smith, Brian R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUINNIPIAC UNIVERSITY   (United States)

^c NEUROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[[BENZYL [[1 BUTYL 2 (3 FLUOROPHENYL) 1H IMIDAZOLE 5YL]ETHYL]AMINO]METHYL] 3 CHLOROPHENOL; BETA2 INTEGRIN; CD11B ANTIGEN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C5B; ELASTASE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INTERLEUKIN 8; IODINE 125; PADGEM PROTEIN; RECEPTOR BLOCKING AGENT; SULFUR 35;

ARTICLE; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

ANTIGENS, CD11B; BLOOD PLATELETS; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; HUMANS; INTERLEUKIN-8; LEUKOCYTE ELASTASE; LEUKOCYTES; NEUTROPHILS; RECEPTOR, ANAPHYLATOXIN C5A;

EID: 33845491736     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.08.019     Document Type: Article

References (42)

1. Gol M.K., Karahan M., Ulus A.T., et al. Bloodstream, respiratory, and deep surgical wound infections after open heart surgery. J Cardiac Surg 13 (1998) 252-259
2. Baufreton C., Allain P., Chevaller A., et al. Brain injury and neuropsychological outcome after coronary artery surgery are affected by complement activation. Ann Thorac Surg 79 (2005) 1597-1605
3. Steinberg J., Kapelanski D., Olson J., and Weiler J.M. Cytokine and complement levels in patients undergoing CPB. J Thorac Cardiovasc Surg 106 (1993) 1008-1016
4. Kappelmayer J., Bernabei A., Gikakis N., et al. Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation. J Lab Clin Med 121 (1993) 118-126
5. Rinder C.S., Rinder H.M., Smith B.R., et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest 96 (1995) 1564-1572
6. Rinder C.S., Rinder H.M., Johnson K., et al. Role of C3 cleavage in monocyte activation during extracorporeal circulation. Circulation 100 (1999) 553-558
7. Rinder C.S., Rinder H.M., Smith M.J., et al. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation. J Thorac Cardiovasc Surg 118 (1999) 460-466
8. Shernan S.K., Fitch J.C., Nussmeier N.A., et al. Impact of Pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing CPB. Ann Thorac Surg 77 (2004) 942-950
9. Rothenburger M., Tjan T.D., Schneider M., et al. The impact of the pro- and anti-inflammatory immune response on ventilation time after cardiac surgery. Cytometry B Clin Cytom 53 (2003) 70-74
10. Huber-Lang M., Riedemann N.C., Sarma J.V., et al. Protection of innate immunity by C5aR antagonist in septic mice. FASEB J 16 (2002) 1567-1574
11. Edmunds L.J. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 66 5 Suppl (1998) S12-S16
12. Braunwalder A.F., Musmanno D., Galakatos N., et al. Characterization of the binding of Bolton-Hunter-labels [125I]C5a to human neutrophil, monocyte, and U-937 cell membranes. Mol Immunol 29 (1992) 1319-1324
13. Wieland T., and Jakobs K.H. Measurement of receptor-stimulated guanosine 5′-O-(gamma-thio)triphosphate binding by G proteins. Met Enzymol 237 (1994) 3-13
14. Johnson R.J., and Chenowith D.E. Labeling the granulocyte C5a receptor with a unique photoreactive probe. J Biol Chem 260 (1985) 7161-7164
15. Rinder C.S., Bonan J., Rinder H.M., et al. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 79 (1992) 1201-1205
16. Michelson A.D., Barnard M., Kruegger L., et al. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than surface P-selectin. Circulation 104 (2001) 1533-1537
17. Horl W.H., Feinstein E.I., Frischmuth C., et al. Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers. Am J Nephrol 10 (1990) 53-57
18. Lappegard K.T., Fung M., Bergseth G., et al. Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition. Ann Thorac Surg 78 (2004) 38-45
19. Lappegard K.T., Fung M., Bergseth G., et al. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. Ann Thorac Surg 77 (2004) 932-941
20. Butler J., Rocker G.M., and Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55 (1993) 552-559
21. Shappell S.B., Toman C., Anderson D.C., et al. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol 144 (1990) 2702-2711
22. Sellke F.W., Shafique T., Ely D.L., and Weintraub R.M. Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals. Circulation 88 Suppl 2 (1993) II-395-II-400
23. Keshavjee S., Davis R.D., Zamora M.R., et al. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg 129 (2005) 423-428
24. Holmes J.H., Connolly N.C., Paull D.L., et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res 51 (2002) 579-586
25. Gessler P., Pretre R., Hohl V., et al. CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock 22 (2004) 513-520
26. Volk T., Schmutzler M., Engelhardt L., et al. Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass. Crit Care Med 29 (2001) 2137-2142
27. Zeiher B.G., Artigas A., Vincent J.L., et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 32 (2004) 1695-1702
28. Fung M., Loubser P.G., Undar A., et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg 122 (2001) 113-122
29. Zeerleder S., Caliezi C., van Mierlo G., et al. Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis. Clin Diagn Lab Immunol 10 (2003) 529-535
30. Norgauer J., Dobos G., Kownatzki E., et al. Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein. Eur J Biochem 217 (1993) 289-294
31. Hanlon W.A., Stolk J., Davies P., et al. rTNF facilitates human polymorphonuclear leukocyte adherence to fibrinogen matrices with mobilization of specific and tertiary but not azurophilic granule markers. J Leuk Biol 50 (1991) 43-48
32. Bohler J., Schollmeyer P., Dressel B., et al. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 7 (1996) 234-241
33. Wachtfogel Y.T., Kettner C., Hack C.E., et al. Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation. Thromb Haemost 80 (1998) 686-691
34. Sutterwala F.S., Rosenthal L.A., and Mosser D.M. Cooperation between CR1 and CR3 in the binding of complement-opsonized particles. J Leuk Biol 59 (1996) 883-890
35. Sorurui A., Riggert J., Schlott T., et al. Anaphylatoxin C5a induces monocyte recruitment and differentiation into dendritic cells by TNF-alpha and prostaglandin E2-dependent mechanisms. J Immunol 171 (2003) 2631-2636
36. Ott I., Neumann F.J., Gawaz M., et al. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 94 (1996) 1239-1246
37. Gardiner E.E., De Luca M., McNally T., et al. Regulation of P-selectin binding to the neutrophil P-selectin counter-recetor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G. Blood 98 (2001) 1440-1447
38. Lorant D.E., McEver R.P., McIntyre T.M., et al. Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces. J Clin Invest 96 (1995) 171-182
39. Cai T.Q., and Wright S.D. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18) and modulates PMN adhesion. J Exp Med 184 (1996) 1213-1223
40. Vandendries E.R., Furie B.C., and Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 92 (2004) 459-466
41. Gemmell C.H. Flow cytometric evaluation of material-induced platelet and complement activation. J Biomater Sci Polym Ed 11 (2000) 1197-1210
42. Sundaram S., Lim F., Cooper S.L., and Colman R.W. Role of leukocytes in coagulation induced by artificial surfaces: investigation of expression of Mac-1, granulocyte elastase release, and leukocyte adhesion on modified polyurethanes. Biomaterials 17 (1996) 1041-1047